Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
135.09B
Market cap135.09B
Price-Earnings ratio
37.87
Price-Earnings ratio37.87
Dividend yield
0.71%
Dividend yield0.71%
Average volume
4.30M
Average volume4.30M
High today
$193.80
High today$193.80
Low today
$188.00
Low today$188.00
Open price
$189.31
Open price$189.31
Volume
2.73M
Volume2.73M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

Danaher(DHR) stock is priced at $191.12, giving the company a market capitalization of 135.09B. It carries a P/E multiple of 37.87 and pays a dividend yield of 71.2%.

During the trading session on 2026-04-03, Danaher(DHR) shares reached a daily high of $193.80 and a low of $188.00. At a current price of $191.12, the stock is +1.7% higher than the low and still -1.4% under the high.

Trading volume for Danaher(DHR) stock has reached 2.73M, versus its average volume of 4.3M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $171.00.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $171.00.

DHR News

Simply Wall St 3d
Is Danaher’s BIO-Europe Spring Focus Sharpening Its Life Sciences Edge or Simply Polishing the Story?

Danaher Corporation recently presented at the BIO-Europe Spring 2026 conference in Lisbon on March 24, 2026, with Senior Director Luciano Lucas speaking to an a...

Is Danaher’s BIO-Europe Spring Focus Sharpening Its Life Sciences Edge or Simply Polishing the Story?
Simply Wall St 6d
A Look At Danaher Valuation After Recent Share Price Weakness

Advertisement Why Danaher (DHR) Is Drawing Attention Now Danaher (DHR) is back on many watchlists after a period of weaker share performance, including a 13%...

A Look At Danaher Valuation After Recent Share Price Weakness

Analyst ratings

86%

of 28 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.